The present invention provides a protein cross-linking inhibitor containing a compound represented by any of the following formulas (
1
)-(
13
), or a pharmaceutically acceptable salt thereof:
R
3
—[—X—B(ZR
1
)—Y—B(ZR
2
)—W—]
n
—R
4
,  (1)
R
3
—[—X—B(ZR
1
)—Y—]
n
—R
4
,  (2)
R
3
—[—B(ZR
1
)—Y—B(ZR
2
)—W—]
n
—R
4
,  (3)
R
3
—[—X—B(ZR
1
)—]
n
—R
4
,  (4)
R
3
—[—B(ZR
2
)—W—]
n
—R
4
,  (5)
R
3
—X—B(ZR
1
)-T[B(ZR
2
)—W—R
4
]
2
,  (6)
R
3
—B(OH)
2
,  (7)
R
3
—B(ZR
1
)—X—B(ZR
2
)—R
4
,  (8)
R
3
—B(R
1
)—O—B(R
2
)—R
4
,  (9)
R
3
—[—X—B(ZR
1
)—Y—B(ZR
2
)—]
n
—R
4
,  (10)
R
3
—[—X—B(ZR
1
)—Y—B(ZR
2
)—W-Q-]
n
—R
4
,  (11)
R
3
—[—P—X—B(ZR
1
)—Y—B(ZR
2
)—W—]
n
—R
4
,  (12)
[R
3
—X—B(ZR
1
)—Y]
2
B(ZR
2
),  (13)
wherein each symbol is as defined in the DESCRIPTION.
                            当前发明提供了一种含有由以下任一公式(1)-(13)表示的化合物的蛋白交联
抑制剂,或其药用可接受的盐:R3—[—X—B(ZR1)—Y—B(ZR2)—W—]n—R4,  (1)R3—[—X—B(ZR1)—Y—]n—R4,  (2)R3—[—B(ZR1)—Y—B(ZR2)—W—]n—R4,  (3)R3—[—X—B(ZR1)—]n—R4,  (4)R3—[—B(ZR2)—W—]n—R4,  (5)R3—X—B(ZR1)-T[B(ZR2)—W—R4]2,  (6)R3—B(OH)2,  (7)R3—B(ZR1)—X—B(ZR2)—R4,  (8)R3—B(R1)—O—B(R2)—R4,  (9)R3—[—X—B(ZR1)—Y—B(ZR2)—]n—R4,  (10)R3—[—X—B(ZR1)—Y—B(ZR2)—W-Q-]n—R4,  (11)R3—[—P—X—B(ZR1)—Y—B(ZR2)—W—]n—R4,  (12)[R3—X—B(ZR1)—Y]2B(ZR2),  (13)其中每个符号如说明书中所定义。